Quality Assessment of Medical Care at the Stage of Primary Healthcare: the Range of Diagnostic Procedures in Patients with Eczema by Cherkashyna, Lidiya
Galician medical journal 2018
Vol. 25, Issue 4, E201845
DOI: 10.21802/gmj.2018.4.5
Public Health Service
Quality Assessment of Medical Care at the Stage of
Primary Healthcare: the Range of Diagnostic
Procedures in Patients with Eczema
Lidiya Cherkashyna
Abstract
According to the results of studying the ranges of diagnostic measures among 75 patients with eczema, primary health
care quality was assessed. The adequacy/completeness of clinical and anamnestic examination of patients with eczema
by general family medicine physicians was at the level of (56.5÷59.8) % being characterized by the underestimation of the
state of skin derivatives (microelementosis, vitamin deficiency) in (86.7±3.9) % of patients; the constitutional and biological
markers, visceral and functional markers of undifferentiated connective tissue dysplasia in (74.7±5.0) % and (74.7±5.0) % of
patients, respectively; the influence of unfavorable regional environmental factors, living conditions and professional activity,
clinical and morphological evaluation of rash in (49.3±5.8) % of patients. According to the generalized quality index, the
adequacy/completeness of clinical and laboratory examination of patients with eczema was at the level of (58.4÷63.4) % being
characterized by a low level of examinations aimed at the detection of possible disorders of microelement homeostasis and
comorbidity. According to the generalized quality index, the adequacy/completeness of clinical and instrumental examination
of patients with eczema was at the level of 66.5 being characterized by a low level of instrumental diagnostics of autonomic
homeostasis state, densitometry, anesthesiometry, imaging study of the joints.
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Problem statement and analysis of the
latest research
Modern trends in the development of general family medicine
(GFM) as a scientific specialty and practical activity deter-
mine the need for developing simple and accessible at the
stage of primary healthcare (PHC) measures for diagnosing
and prognosing an exacerbated clinical course of chronic
dermatoses (CD) with the use of clinical and anamnestic mea-
sures (CAM), clinical and laboratory measures (CLM), clin-
ical and instrumental measures (CIM) by a GFM physician
[3, 10, 11]. This problem is especially relevant due to sub-
sequent reform of the field on the basis of GFM principles,
as well as the need for care coordination for patients with
eczema and interdisciplinary cooperation [6, 11, 12]. The
aspects of the collaboration between GFM physicians and
dermatovenerologists such as examination phasing, forms and
methods of long-term observation of patients with eczema,
family-level preventive activities carried out by GFM physi-
cians to ensure the psychosocial well-being of patients with
eczema have not been sufficiently studied yet [7, 8, 9]. There-
fore, the development of methods for quality assessment of
the diagnostic, therapeutic and prophylactic processes when
providing care to patients with eczema at the stage of PHC is
of special importance [3, 6].
The objective of the research was to study the range and
adequacy of diagnostic procedures carried out by primary care
physicians when providing care to patients with eczema con-
sidering anamnestic, laboratory and instrumental components.
1. Materials and Methods
The analysis of diagnostic procedure adequacy at the stage of
PHC was conducted in 75 patients with eczema depending
on its severity considering clinical and anamnestic, laboratory
and instrumental components of the diagnostic process. To
study the frequency of using certain diagnostic procedures,
there was developed an expert evaluation record which in-
cluded the data from the outpatient medical record (f.025/o)
and/or medical history (f.003/o) of patients with CD. Consid-
ering the process of ensuring quality diagnostic process as a
multicomponent system (clinical and anamnestic, clinical and
laboratory, clinical and instrumental components), we have
determined the choice of the methods of systematic approach,
assessment and analysis. According to the theory and prac-
tice of multicomponent system functioning, the level of the
system (in our case diagnostic one) arrangement is of great
importance [1]. Therefore, to obtain an integral assessment of
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the diagnostic process quality, there were used the indicators
of the arrangement of diagnostic complex system; the entropy
index (h, bit) of each indicator was calculated for each group
of patients. The entropic value of the quality index (h, bit) was
determined by the formula h=-k×log2k, where k was the fre-
quency of using a specific type of diagnostic procedures, while
the value of the generalized quality index (H, bit) was calcu-
lated by the formula =n-(h1+h2+h3+. . . +hn), where n was the
number of assessment indicators in the corresponding diag-
nostic component [1, 4, 5]. Clinical and statistical, clinical
and informational methods, namely: anamnestic quantitative
assessment, variational statistics, probability distribution of
clinical signs with the assessment of the reliability of the re-
sults obtained were used when conducting statistical analysis
[4].
2. Results and Discussion
Seventy-five patients with eczema were examined by primary
care physicians: anamnestic data for the detection of the typ-
ical complaints (CAM1) were collected in (69.3±5.3) % of
patients only; (73.7±7.1) % of patients with mild eczema
and (51.1±7.8) % of patients with moderate eczema were
interviewed to take anamnesis related to seasonal eczema
exacerbations (CAM2), p<0.05; anamnesis related to fam-
ily history of CD (CAM3) was taken from (50.7±5.8) % of
patients ((42.1±8.0) % of patients with mild eczema and
(46.8±8.1) % of patients with moderate eczema, p>0.05)
(Table 1). Among (72.0±5.2) % of patients with eczema,
stress-inducing factors were determined/analyzed (CAM4)
and the psychological state was assessed in (76.3±6.9) % of
patients with mild eczema and (53.2±7.7) % of patients with
moderate eczema, p<0.05, while clinical and morphological
evaluation of rash (according to IASI system; CAM5) was
performed in (50.7±5.8) % of patients only.
Clinical evaluation of skin derivatives to identify the pres-
ence/absence of microelementosis or vitamin deficiency signs
was performed in (13.3±3.9) % of patients only; there was
observed an insufficient clinical and anamnestic evaluation
of this sign (CAM6) among patients with both moderate and
mild eczema - (12.8±6.1) % and (10.5±5.0) %, respectively,
p>0.05. During clinical and anamnestic study, the analysis of
elimination behavior related to risk factors triggering the exac-
erbation of eczema clinical course (CAM7) was conducted in
(25.3±5.0) % of patients; therapeutic and prognostic indica-
tors, namely the constitutional and biological markers (CBM;
CAM8), visceral and functional markers (VFM; CAM9) were
registered in (25.3±5.0) % of patients; the registration fre-
quency did not depend on CD severity. At the same time,
the analysis of potential influence of regional environmental
factors (REF; CAM10) on the patient’s well-being and the clin-
ical course of the disease was conducted significantly more
often – in (50.7±5.8) % of cases.
The analysis of using laboratory diagnostics among pa-
tients with eczema at the stage of PHC was conducted depend-
ing on disease severity
Seventy-five patients with eczema were examined by pri-
mary care physicians: in (96.4±1.3) % of cases, the Wasser-
mann test/the microprecipitation test (CLM1) were done; a
complete blood count (CLM2; including the ESR and platelet
count) was used in the absolute majority of cases ((79.1±5.4) %
- (87.2±8.0) % of patients with moderate eczema and (73.0±5.5) %
of patients with mild eczema, p>0.05) (Table 2).
A C-reactive protein test (CLM3) was done in (68.2±5.3) %
of cases ((58.7±7.8) % of patients with mild eczema and
(80.0±7.1) % of patients with moderate eczema, p<0.05).
Serum alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) (CLM4) were determined biochemically in
(53.6±5.8) % of cases ((47.6±8.1) % of patients with mild
eczema and (61.7±8.1) % of patients with moderate eczema,
p>0.05). Clinical and laboratory examination of patients with
moderate eczema included the determination of blood glu-
cose (CLM5) and lipid profile (CLM6) more often. Clinical
and laboratory examination of (7.3±3.4) % of patients with
mild eczema included the study of blood serum micro- and
macroelements/hair/urine (the results were almost not taken
into consideration).
The analysis of the range of instrumental diagnostic pro-
cedures at the stage of providing PHC to patients with eczema
depending on disease severity allowed us to determine the
diagnostic adequacy of clinical and instrumental component
(Table 3).
Among 75 patients with eczema being examined by pri-
mary care physicians, fluorography/chest X-ray (CIM1) were
used in all the cases, while diagnostics of dental health or ENT
organs with subsequent determination of treatment strategy
were applied in (84.08±4.2) % of cases ((91.9±4.5) % of
patients with moderate eczema and (76.3±6.9) % of patients
with mild eczema, p<0.05).
The frequency of using 2 X-ray projection or ultrasound
examination of the joints (CIM3) averaged (18.7±4.5) %. The
electrocardiogram (ECG), blood pressure (BP) control and
personalized cardiovascular risk (CVR) assessment (CIM4)
were used in (73.3±5.1) % of cases - (63.2±7.8) % of patients
with mild eczema and (83.8±6.1) % of patients with moderate
eczema, p&lt; 0.05.
Complete physical examination of patients with eczema in-
cluded imaging study of the gallbladder and bile ducts (CIM5)
in (26.7±5.1) % of cases; the frequency of using these exam-
inations did not depend on disease severity. Imaging study
of the kidneys (CIM6) was performed in (28.0±5.2) % of
cases. The methods such as bone densitometry (X-ray, ultra-
sound examination) (CIM7), pulmonary function test (CIM8),
autonomic status assessment (CIM9) and pain threshold as-
sessment (CIM10) being predictively and diagnostically sig-
nificant were more rarely used (at the level of 15.0% and less)
during clinical and instrumental diagnostics of patients with
mild eczema.
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Table 1. Range of diagnostic procedures at the stage of providing PHC to patients with eczema depending on disease severity:
clinical and anamnestic component of diagnostic adequacy
Group of patients with eczema (L30)
Clinical and anamnestic diagnostic measures and corre-
sponding qualimetric coefficients
mild eczema moderate eczema Total (nE=75)
h, bit P±m, % h, bit P±m, % h, bit P±m, %
CAM1: anamnestic detection of the typical complaints 0 100 0 100 0 100
CAM2: anamnesis (seasonal exacerbations, trigger fac-
tors)
0.325 73.7±7.1 a 0.495 51.1±7.8 0.366 69.3±5.3
CAM3: assessment of family history of CD 0.525 42.1±8.0 0.473 46.8±8.1 0.468 50.7±5.8
CAM4: assessment of the psychological state, analysis of
stress-inducing factors
0.298 76.3±6.9 a 0.484 53.2±7.7 0.341 72.0±5.2
CAM5: clinical and morphological evaluation of rash
(IASI)
0.519 44.7±8.1 0.519 44.7±8.1 0.497 50.7±5.8
CAM6: clinical evaluation of skin derivatives (microele-
mentosis, vitamin deficiency)
0.342 10.5±5.0 0.379 12.8±6.1 0.388 13.3±3.9
CAM7: analysis of elimination behavior and CD clinical
course
0.525 31.6±7.5 0.52 29.8±8.0 0.53 34.7±5.5
CAM8: CBM registration 0.492 21.1±6.6 0.475 23.4±7.5 0.502 25.3±5.0
CAM9: VFM registration 0.473 23.7±6.9 0.49 21.3±7.3 0.502 25.3±5.0
CAM10: analysis of the influence of REF, living condi-
tions and profession
0.525 42.1±8.0 0.513 46.8±8.1 0.497 50.7±5.8
HCAM, bit 5.975 - 5.651 - 5.909 -
Notes.
a - significant difference in the frequency of usage depending on dermatosis severity;
h - entropic value of the indicator, bit;
HCAM - quality indicator of clinical and anamnestic examination, bit.
3. Conclusions
1. According to the generalized quality index, the ade-
quacy/completeness of clinical and anamnestic exami-
nation of patients with eczema by GFM physicians was
at the level of (56.5÷59.8)% being characterized by
the underestimation of the state of skin derivatives (mi-
croelementosis, vitamin deficiency) in (86.7±3.9)% of
patients; the CBM and VFM of undifferentiated connec-
tive tissue dysplasia in (74.7±5.0)% and (74.7±5.0)%
of patients, respectively; the influence of unfavorable
REF, living conditions and professional activity, clinical
and morphological evaluation of rash in (49.3±5.8)%
of patients.
2. According to the generalized quality index, the ade-
quacy/completeness of clinical and laboratory exam-
ination of patients with eczema at the stage of PHC
was at the level of (58.4÷63.4)% being characterized
by a low level of examinations aimed at the detection
of possible disorders of microelement homeostasis and
comorbidity.
3. According to the generalized quality index, the ade-
quacy/completeness of clinical and instrumental exami-
nation of patients with eczema at the stage of PHC was
at the level of 66.5 being characterized by a low level
of instrumental diagnostics of autonomic homeostasis
state, densitometry, anesthesiometry, imaging study of
the joints.
4. Depending on eczema severity, there were differences
in the ranges of diagnostic measures and, accordingly,
the indicators of diagnostic process quality: anamnes-
tic and laboratory examinations were more often used
when examining patients with mild eczema; labora-
tory examinations were more commonly used when
examining patients with moderate eczema; instrumen-
tal diagnostics was applied equally frequently.
4. Prospects of Further Researches
The study of the influence of diagnostic process quality on
the clinical course of chronic eczema at the stage of PHC
and the characteristics of the formation of long-term relation-
ships between a patient with eczema and a GFM physician is
promising.
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Table 2. Range of diagnostic procedures at the stage of providing PHC to patients with eczema depending on disease severity:
laboratory component of diagnostic adequacy
Group of patients with eczema (L30)
Clinical and anamnestic diagnostic measures and corre-
sponding qualimetric coefficients
mild eczema moderate eczema Total (nE=75)
h, bit P±m, % h, bit P±m, % h, bit P±m, %
CLM1: the microprecipitation test/the Wassermann test 0.045 96.8±2.6 0.06 95.7±2.7 0.051 96.4±1.3
CLM2: complete blood count 0.331 73.0±5.5 0.172 87.2±8.0 0.268 79.1±5.4
CLM3: C-reactive protein test 0.451 58.7±7.8 0.248 80.9±7.1 0.377 68.2±5.3
CLM4: ALT and AST 0.51 47.6±8.1 0.43 61.7±8.1 0.482 53.6±5.8
CLM5: blood glucose 0.375 34.9±7.5 0.347 66.0±5.1 a 0.344 48.2±4.7
CLM6: lipid profile (total cholesterol, triglycerides
lipoproteins)
0.515 46.0±8.1 0.505 48.9±8.1 0.511 47.3±5.4
CLM7: allergen skin tests 0.526 31.7±7.8 0.53 38.3±8.1 0.53 34.5±5.8
CLM8: total bilirubin 0.522 30.2±6.9 0.459 57.4±8.1 0.526 41.8±5.4
CLM9: immunologic study 0.529 39.7±8.7 0.513 46.8±8.1 0.524 42.7±5.8
CLM10: study of blood serum micro- and macroelements 0.209 4.8±3.6 0.344 10.6±5.6 0.275 7.3±3.4
HCLM, bit 5.839 - 6.344 - 5.949 -
Notes.
a - significant difference in the frequency of usage depending on dermatosis severity;
h - entropic value of the indicator, bit;
HCLM - quality indicator of clinical and laboratory examination, bit.
Table 3. Range of diagnostic procedures at the stage of providing PHC to patients with eczema depending on disease severity:
clinical and instrumental component of diagnostic adequacy
Group of patients with eczema (L30)
Clinical and anamnestic diagnostic measures and corre-
sponding qualimetric coefficients
mild eczema moderate eczema Total (nE=75)
h, bit P±m, % h, bit P±m, % h, bit P±m, %
CIM1: fluorography/chest X-ray 0 100 0 100 0 100
CIM2: diagnostics of dental health/ diagnostics of ENT
organs
0.298 76.3±6.9 0.112 91.9±4.5 a 0.211 84.0±4.2
CIM3: 2 X-ray projection/ultrasound examination of the
joints
0.42 15.8±5.9 0.478 21.6±6.8 0.452 18.7±4.5
CIM4: ECG, BP control and CVR assessment 0.419 63.2±7.8 0.214 83.8±6.1 a 0.328 73.3±5.1
CIM5: imaging study of the gallbladder and bile ducts 0.492 23.7±6.9 0.52 29.7±7.5 0.509 26.7±5.1
CIM6: imaging study of the kidneys and the urinary sys-
tem
0.518 28.9±7.7 0.51 27.0±7.3 0.514 28.0±5.2
CIM7: bone densitometry (X-ray, ultrasound examina-
tion)
0.289 7.9±4.4 0.454 18.9±6.4 0.388 13.3±3.9
CIM8: pulmonary function test 0.342 10.5±5.0 0.347 10.8±5.1 0.344 10.7±3.6
CIM9: instrumental/tabular autonomic status assessment 0.385 13.2±5.5 0.478 21.6±6.7 0.438 17.3±4.4
CIM10: pain threshold assessment (anesthesiometry) 0.289 7.9±4.4 0.347 10.8±4.5 0.319 9.3±3.4
HCIM, bit 6.548 - 6.54 - 6.496 -
Notes.
a - significant difference in the frequency of usage depending on dermatosis severity;
h - entropic value of the indicator, bit;
HCIM - quality indicator of clinical and instrumental examination, bit.
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